Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Clinical Pharmacist Intervetion: The patient with skin complaints at the dermatology department screened for tinea will be included in the study and a questionnaire will be carried usin
Sponsors
KLE college of pharmacy
Eligibility
Inclusion criteria
Inclusion criteria: Patient diagnosed with Tinea infection Patient aged 18 years and above of any gender Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients with mixed skin infections Severely immunocompromised patients Patients with cognitive impairment or those who are critically ill Drug induced skin infection cases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the medication asherence among Tinea patients measured by the TSQM or similar adherence scales To assesss the patient satisfaction with their therapy via TSQM or a validated satisfaction tool Overall health outcomes related to Tinea infection tracked using HOLMES scale or another relevant health statusTimepoint: 7 days 7 to 14 days 15 to 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatological Quality of life improvement in Tinea patients as result of clinical pharmacist caremeasured by DLQI or equivalentTimepoint: 7 days 15 days 30 days | — |
Countries
India
Contacts
Public ContactArslan Hawaldar
KLE college of pharmacy
Outcome results
None listed